28 results
8-K
EX-10.1
KANT
Kineta, Inc.
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
to engage in concerted activities for the purpose of collective bargaining or other mutual aid or protection or (z) prevents you from discussing
8-K
EX-10.2
KANT
Kineta, Inc.
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
activities for the purpose of collective bargaining or other mutual aid or protection or (z) prevents you from discussing or disclosing conduct
8-K
EX-10.1
KANT
Kineta, Inc.
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement
8-K
EX-10.1
KANT
Kineta, Inc.
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement
8-K
EX-99.6
uzor9
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
425
8itfuom
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.6
80pkk9uvtlx6v
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.2
2o13y6t
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K/A
EX-99.3
ywsycfzey6h4
3 Feb 21
Other Events
4:59pm
8-K
EX-10.1
u9jyv4s5f5 wd7x7
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
425
EX-10.1
3p72upjargta
15 Dec 20
Business combination disclosure
7:32am
8-K
EX-2.1
05dia 55kn3m
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-2.1
bd2kvt ey90kjnj
24 Aug 20
Business combination disclosure
5:28pm
424B5
edojr71dglqzufft0e
9 May 19
Prospectus supplement for primary offering
8:06am